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1. Introduction
In health sciences, the main focus is on health care using both preventive and curative actions, 
which are constantly evolving and being updated. In this context, research that contributes 
with evidence to the decision-making of health professionals is required to adequately under-
stand health problems, as well as implement health interventions.
The fundamental aim of research in the health field is to enrich knowledge about the patho-
physiological and epidemiological mechanisms of diseases and health problems and propose 
strategies for their prevention and treatment through different approaches and methodolo-
gies, including basic or preclinical research, clinical research, and epidemiological research in 
public health (Figure 1).
The basic or preclinical research seeks a better knowledge of the molecular, biochemical, and 
cellular mechanisms involved in the etiopathogenesis of diseases, forming the basis on which 
future studies are constructed [1]. Clinical research studies the prevention, diagnosis, and 
treatment of diseases along with the knowledge of their natural history that can be catego-
rized by the period of data collection (prospective, retrospective, and transversal) as well as 
by its design (observational or experimental), each with its own strengths and weaknesses [2]. 
Finally, epidemiological research in public health and health services studies the frequency, 
distribution, and the health needs of the population, their risk factors, and their impact on 
public health [3].
In general, biomedical research consists of two main categories: in an experimental 
approach, the researcher deliberately exposes the subjects to a specific treatment or inter-
vention and observes the results. These results can be compared with those obtained by a 
different treatment. However, in daily clinical practice, experimental studies are difficult to 
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carry out and often impose enormous logistical and budgetary challenges that are not easy 
to face. Therefore, health professionals can usually only observe situations and phenomena 
which are already segregated in groups. Therefore, researchers cannot assign an exposure or 
treatment, but only observe the results. This observational approach constitutes the typical 
environment of most clinical studies. In this context, observational studies can be classified 
according to the presence of a comparison group. When a comparison group is provided, the 
study is defined as analytical, otherwise it is considered a description. In cohort studies, the 
design is similar to that of clinical trials, considered the most appropriate for causal infer-
ence, with the difference that exposure occurs naturally and is determined by preferences, 
clinical decisions or other conditions.
As previously shown, cohorts, as well as other observational studies, have several advantages 
over randomized and controlled trials, including a lower cost, greater opportunity, and a 
wider range of patients. However, concerns about the inherent bias in these studies have 
limited their use when comparing treatments. Therefore, observational studies are mainly 
used to identify risk factors and prognostic indicators, and in situations where randomized 
controlled trials would be impossible or unethical [1]. Benson et al. [1] suggested that obser-
vational studies usually provide valid information and could be used to explore the available 
databases. Only with a greater willingness to analyze these databases would it be possible 
Figure 1. Approaches to research in health sciences.
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to achieve a realistic understanding of how observational studies can best be used. It should 
be noted that although clinical trials are considered the gold standard of clinical studies and 
are at the top of the traditional pyramid of scientific evidence, there may be limitations, for 
example, external validity that favors designs such as cohort studies [2]. Therefore, regardless 
of the type of research performed or evaluated in the clinical context, there must be appropri-
ate tools to discriminate the best available evidence for health decision making [3].
2. General aspects of cohort studies
Cohort studies are similar to experimental studies since they are compared, exposed, and 
unexposed. The difference is that the researcher does not decide who is exposed, that is, does 
not assign the subject to one group or another; the patients go to one group to another for 
reasons of routine or daily clinical practice.
The word cohort means a group or group of people and has traditionally been associated 
with the military concept of the infantry corps of ancient Rome [4]. Consequently, the term 
cohort in clinical research is used to designate a group of subjects that have a characteristic, or 
a set of characteristics, in common (factor of study or exposure), and are followed over time 
[4–6]. In general, in these types of studies, a group of individuals is recruited, none of which 
manifests the study event at the time of recruitment, but all of which are at risk of suffering 
or presenting the event [5–8]. This type of study can adopt a prospective, retrospective or 
ambidirectional modality [4, 8–11] (Figure 2).
Prospective studies are planned in advance and carried out in a future period of time. The 
researchers pose a question and form a hypothesis about what might cause a disease and then 
observe a group of people over a period of time that can take several years. They collect data 
that may be relevant to the outcome or disease under study and, in this way, aim to detect any 
change in health related to the possible risk factors that they have identified.
Retrospective cohort studies examine the existing data and attempt to identify risk factors 
for particular conditions. For example, existing medical records are used to look back in time 
to identify exposed and unexposed subjects and the subsequent development (or not) of the 
study outcome. The study maintains the sequence from the exposure to the result, although 
the data collection occurred after the fact. In this case, interpretations are limited because 
researchers cannot go back and collect missing data.
As the name implies, in ambidirectional studies, data collection goes in both directions. 
This approach can be useful for exposures that have both short- and long-term results. The 
researcher can look back through the records that have already been collected and begin to 
track the subjects in the future for the onset of the outcome, or disease.
Cohorts can also be classified as closed (fixed) or open (dynamic) cohorts [5, 6, 8]. Closed or 
fixed cohorts (Figure 3) are study designs that do not consider the inclusion of a population 
under study beyond the recruitment period set by the researchers. That is, the participants are 
recruited in the same period of time and do not allow the entry of new individuals during the 
follow-up. All members have follow-up periods that begin at the same time.
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In contrast, in an open or dynamic cohort, individuals can enter the cohort at different times 
during the study period. The study allows the entry and exit of new study subjects during 
the follow-up phase, so the number of members may vary over time. Participants can enter or 
leave the cohort when they meet eligibility criteria and are often defined by geographic units 
and population groups (Figure 4).
Figure 2. Cohort study designs.
Figure 3. Closed (fixed) cohort study.
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Some limitations should be considered when designing or analyzing a cohort study. For 
example, they are less suitable for studying rare diseases or diseases with a very long latency. 
In general, they are inadequate for identifying the causes of a sudden disease outbreak. Like 
any observational researches, it offers clues about the causes of the disease, rather than defini-
tive evidence of the links between risk factors and health. Participants can leave the cohort, 
perhaps move away, lose contact or die from a cause that is not being studied. This can pro-
duce a bias in the results.
3. The contribution of cohort studies as evidence in health research
Compared with randomized controlled trials (RCTs), observational studies are likely to be 
faster, less expensive, and include patients that are more representative of routine clinical 
practice. Also, they avoid the ethical problems caused by the commitment of the therapeutic 
options. However, validity can be questioned by the inherent limitations of the design [12].
Analyzing the differences between the results of observational studies—such as cohort stud-
ies—and clinical trials suggests that there is little evidence of significant differences when esti-
mating the effects between observational studies and RCTs, regardless of the study design, the 
heterogeneity or the inclusion of studies with pharmacological interventions. Consequently, 
when exploring the reasons for the lack of consistency between results from the RCTs and obser-
vational studies, other factors must be taken into account apart from the study design per se [13].
However, even with the mentioned limitations, cohort studies have delivered important find-
ings that contribute to the understanding of multiple diseases and their risk factors (Table 1), 
for example, the Framingham Heart Study and the Nurses’ Health Study, among others.
Figure 4. Open (dynamic) cohort study.
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Name of cohort 
study
Type of cohort 
study
Year Participants Purpose
Framingham 
heart study 
[14–16]
Prospective 1948 5209 men and women 
in ages of 30–62 years 
residents of the eastern 
Massachusetts town of 
Framingham
To examine the relationship between 
several factors and cardiovascular disease
British doctors’ 
cohort study [17]
Prospective 1951 34,439 British male 
doctors
To assess the risk associated to smoking 
habits (lung cancer)
Whitehall study I 
[18–20]
Prospective 1967 19,019 male civil 
service (government) 
employees from 
London, United 
Kingdom aged 
40–69 years
To examine the role of social determinants 
in health; association of socioeconomic, 
behavioral, and metabolic characteristics 
with the risk of prostate cancer mortality; 
To assess life expectancy in relation to 
cardiovascular risk factors recorded in 
middle age
Nurses’ health 
study [21, 22]
Prospective 1976 121,701 female 
registered nurses
The primary goal of the study was to 
evaluate the long-term consequences of 
oral contraceptive (OC) use, particularly its 
potential association with breast cancer risk
Whitehall study 
II [23–25]
Prospective 1986 10,308 (6895 men 
and 3413 women) 
civil servant aged 
35–55 years
Role of social determinants of disease 
and mortality; to evaluate effect on health 
and disease of the work environment, the 
moderating effect on these relationships 
of social supports, and, the interaction 
between psychosocial factors in the etiology 
of chronic disease
European 
prospective 
investigation 
into cancer and 
nutrition (EPIC 
study) [26, 27]
Prospective 1992 521,457 adults, 
recruited by 23 centers 
in 10 European 
countries
To examine the relationship between diet 
and cancer
The Korea 
nurses’ health 
study (KNHS) 
[28, 29]
Prospective 2013 20,213 female 
registered nurses 
aged 20–45 years from 
Republic of Korea
To evaluate the effects of occupational, 
environmental, and lifestyle risk factors on 
the health
The Dutch 
famine birth 
cohort study [30]
Retrospective 1944/1946 1116 Dutch female 
children born I 
Amsterdam during the 
“Hunger Winter”
To examine short- and long-term effects 
of a limited period of extreme nutritional 
deprivation
Seveso women’s 
health study 
[31, 32]
Retrospective 1976 Women who were 
newborn to 40 years 
of age on July 10, 
1976 residing around 
Seveso, Italy at the 
time of an industrial 
accident on July 10, 
1976
To study the relationship of dioxin (TCDD) 
on reproductive health
Table 1. Examples of cohort studies.
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4. Conclusion
Cohort studies are classified as the most robust form of medical research after experiments such 
as randomized controlled trials and may be the only alternative for evaluating causal relation-
ships when it is impossible to perform experimental studies. Therefore, cohorts should be con-
sidered for studying various health problems both in hospitals and in the ambulatory context.
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